ALFREDO
RODRIGUEZ-ANTIGUEDAD ZARRANZ
IRAKASLE ELKARTUA
![Foto de ALFREDO](/img/nophoto.png)
![Foto de Hospital Universitario de Basurto](/img/noimage_org.png)
Hospital Universitario de Basurto
Bilbao, EspañaHospital Universitario de Basurto-ko ikertzaileekin lankidetzan egindako argitalpenak (41)
2023
-
Planificación familiar en hombres y mujeres con esclerosis múltiple. Análisis del Registro Andaluz (2018-2022)
Revista de neurologia, Vol. 76, Núm. 12, pp. 377-383
2019
2018
-
Exome sequencing study in patients with multiple sclerosis reveals variants associated with disease course 06 Biological Sciences 0604 Genetics 11 Medical and Health Sciences 1109 Neurosciences
Journal of Neuroinflammation, Vol. 15, Núm. 1
-
Integrative group-based cognitive rehabilitation efficacy in multiple sclerosis: a randomized clinical trial
Disability and Rehabilitation, Vol. 40, Núm. 2, pp. 208-216
2017
-
The influence of posterior visual pathway damage on visual information processing speed in multiple sclerosis
Multiple Sclerosis, Vol. 23, Núm. 9, pp. 1276-1288
2016
-
Long-term adherence to IFN beta-1a treatment when using rebismart1device in patients with relapsing-remitting multiple sclerosis
PLoS ONE, Vol. 11, Núm. 8
-
Revisión de las novedades del XXXI Congreso ECTRIMS 2015, presentadas en la VIII Reunión Post-ECTRIMS
Revista de Neurologia, Vol. 62, Núm. 12, pp. 559-569
2015
-
Assessment of the reproducibility of oligoclonal IgM band detection for its application in daily clinical practice
Clinica Chimica Acta, Vol. 438, pp. 67-69
-
Cell-specific effects in different immune subsets associated with SOCS1 genotypes in multiple sclerosis
Multiple Sclerosis, Vol. 21, Núm. 12, pp. 1498-1512
-
Consenso español actualizado sobre el uso del natalizumab (Tysabri®)-2013
Neurologia, Vol. 30, Núm. 5, pp. 302-314
-
FTY720 attenuates excitotoxicity and neuroinflammation
Journal of Neuroinflammation, Vol. 12, Núm. 1
-
Pharmacogenomic study in patients with multiple sclerosis Responders and nonresponders to IFN-β
Neurology: Neuroimmunology and NeuroInflammation, Vol. 2, Núm. 5, pp. e154
-
Review of the novelties from the 2014 ECTRIMS-ACTRIMS joint congress, presented at the 7th post-ECTRIMS meeting (II)
Revista de Neurologia, Vol. 61, Núm. 6, pp. 271-283
-
Review of the novelties from the 2014 ectrims-actrims joint congress, presented at the 7th post-ectrims meeting (i)
Revista de Neurologia, Vol. 61, Núm. 5, pp. 215-224
2014
-
Autophagic marker MAP1LC3B expression levels are associated with carotid atherosclerosis symptomatology
PLoS ONE, Vol. 9, Núm. 12
-
Biomarkers in multiple sclerosis: An update for 2014
Revista de Neurologia, Vol. 58, Núm. 12, pp. 553-570
-
Review of the novelties presented at the 29th Congress of the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS) (II)
Revista de Neurologia, Vol. 59, Núm. 7, pp. 307-316
-
Revisión de las novedades presentadas en el XXIX congreso del comité Europeo para el tratamiento e investigación en esclerosis múltiple (ECTRIMS) (III)
Revista de Neurologia, Vol. 59, Núm. 8, pp. 371-379
-
Revisión de las novedades presentadas en el xxix congreso del comité europeo para el tratamiento e investigación en esclerosis múltiple (ECTRIMS) (I)
Revista de Neurologia, Vol. 59, Núm. 6, pp. 269-280
-
Usefulness of electronic drug registers: Spanish register of patients treated with fingolimod (Gilenya ®)
Revista de Neurologia, Vol. 58, Núm. 2, pp. 77-83